Home Innovation

INNOVATION

October 21, 2025

Zai Lab initiates global Phase III trial for its DLL3-targeting ADC ZL-1310

This global Phase III clinical trial plans to enroll 665 patients with advanced small cell lung cancer and is expected to be initially completed in November 2028.

October 23, 2025

Gushengtang TCM and 1doc form strategic partnership to establish Singapore's integrated TCM service model

October 21, 2025

Summit to seek FDA approval for Akeso’s ivonescimab for EGFR-TKI resistant NSCLC in Q4 2025

October 17, 2025

Henlius announces US ODD for HLX43, the world's first PD-L1 ADC for thymic epithelial tumors

October 16, 2025

Genesis Healthcare cooperates with MGI to advance precision medicine in Japan

October 16, 2025

Haihe Biopharma enters into exclusive license agreement with Taiho Pharma for PI3Kα inhibitor risovalisib (CYH33) in Japan

October 16, 2025

GenAns' GA001 gene therapy cleared by FDA for Phase II clinical trial

October 15, 2025

jMedtech and Hydromer forge strategic partnership to build a future-ready global medical device coating platform

October 14, 2025

Casibrain secures market approval for world's first non-invasive whole-brain multi-channel cerebral oximetry monitor in China

October 14, 2025

After GLP-1, what's the next blockbuster in weight loss?

October 13, 2025

BeOne Medicines' sonrotoclax granted Breakthrough Therapy Designation by U.S. FDA

October 13, 2025

Singlera' ColonAiQ® enters Thai market, accelerating Asia-Pacific deployment of novel colorectal cancer early-detection technology

October 13, 2025

ReviR Therapeutics receives Orphan Drug Designation from FDA for RTX-117 to treat Charcot-Marie-Tooth disease

October 13, 2025

Beihai Biotech's Class 1 novel drug BH1621 has IND application cleared by U.S. FDA

October 11, 2025

Merson Pharma’s Timolol Maleate Gel, world’s first topical treatment for infant hemangioma, approved in China

October 09, 2025

TAHO Pharma submits FDA application for world's first Apixaban Oral Dissolving Film

October 08, 2025

InnoCare Pharma and Zenas BioPharma announce over $2 billion license agreement for three autoimmune product candidates

October 08, 2025

Core Medical's Corheart® 6 reaches 1,000-implant milestone, ushering in a new era of Chinese innovation in global artificial heart arena

September 30, 2025

RemeGen and Santen announce NDA acceptance in China for RC28-E in diabetic macular edema

September 30, 2025

Product Innovation in PCCT: what forces are currently challenging SlEMENS' monopoly?

September 30, 2025

Product Innovation in PCCT: the race to reshape the landscape of medical imaging has quietly begun